Company: CMND
Filing Date: 2025-06-12
Form Type: POS AM
Source: 0001213900-25-053898
Chunk: 42

Company: Clearmind Medicine Inc.
Filing Date: 2025-06-12
Form: POS AM
Chunk 42
---
 employees, directors, consultants and service providers under our Executive Stock Option and Restricted
Share Unit Plans. There are currently an aggregate of 151,813 stock options and RSU’s outstanding, with exercise prices ranging
from $23.40 to $646.74 per share.

Item 8. Exhibits and Financial Statement Schedules.

(a) Exhibits.See the Exhibit Index attached
to this registration statement, which is incorporated by reference herein.

(b) Financial Statement Schedules. Schedules
not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial
statements or notes thereto.

<div align='center'>II-2</div>

Item 9. Undertakings.

| (a) | The                                       
 undersigned Registrant hereby undertakes: |

| (1) | To                                                                                          
 file, during any period in which offers or sales are being made, a post-effective amendment 
 to this registration statement:                                                             |

| i. | To                                                                         
 include any prospectus required by section 10(a)(3) of the Securities Act; |

| ii. | To                                                                                                   
 reflect in the prospectus any facts or events arising after the effective date of the registration   
 statement (or the most recent post-effective amendment thereof) which, individually                  
 or in the aggregate, represent a fundamental change in the information set forth in the registration 
 statement. Notwithstanding the foregoing, any increase or decrease in volume of securities           
 offered (if the total dollar value of securities offered would not exceed that which was             
 registered) and any deviation from the low or high end of the estimated maximum offering             
 range may be reflected in the form of prospectus filed with the Commission pursuant to Rule          
 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change       
 in the maximum aggregate offering price set forth in the “Calculation of Registration                
 Fee” table in the effective registration statement;                                                  |

| iii. | To include any material information with respect to                                                                               
 the plan of distribution not previously disclosed in the registration statement or any material change to such information in the 
 registration statement.                                                                                                           |

| (2) | That, for the purpose of determining any liability                                                                                    
 under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to           
 the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering